endometrial cancer
Conditions
Interventions
Measure the endometrial thickness by transvaginal ultorasonography
Sponsors
Mizuho Women's Clinic
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Persons who visit the clinic of office genecology, without endometrial disease
Exclusion criteria
Exclusion criteria: 1) Persons receiving the medicine which have an effect on the endometrial thickness such like hormone therapy or tamoxifen 2) Persons who have a difficulty in measuring the endometrial thickness because of clinical factor such like myoma uteri or adenomyosis 3) Persons with endometrial polyp 4) Persons with endometrial cancer or endometrial hyperplasia 5) Persons receiving medicine for sterility 6) Users of foods or supplement which might affect the endometrial thickness (placenta etc) 7) Persons who have been judged to be inappropriate for the study by a researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| mean endometrial thickness | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between mean endometrial thickness and clinical factor (symptoms, risk factor of endometrial cancer, examinee's place of residence) | — |
Countries
Japan
Contacts
Public ContactHiroshi Tsuda
Mizuho Women's Clinic Obstetrics and Gynecology
Outcome results
None listed